Luterion Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
4
Ending by 2030
Feb 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 2, 2027The maintenance fee for Method for diagnosis of diseases using morphological characteristics of luterial (US 10,338,061) comes due Jan 2, 2027. Unpaid by Jul 2, 2027, it lapses early.
- 1 fee due Mar 10, 2027The maintenance fee for Method for inhibiting telomerase in cancer cell using luterion (US 10,406,188) comes due Mar 10, 2027. Unpaid by Sep 10, 2027, it lapses early.
- 1 fee due Aug 25, 2027The maintenance fee for Luterion and Separating and Culturing Methods for Same (US 10,569,194) comes due Aug 25, 2027. Unpaid by Feb 25, 2028, it lapses early.
- 1 fee due Sep 17, 2027The maintenance fee for Luterial and method for isolating and culturing the same (US 10,590,384) comes due Sep 17, 2027. Unpaid by Mar 17, 2028, it lapses early.
- 1 fee due Oct 21, 2027The maintenance fee for Luterial and Method for Isolating and Culturing the Same (US 10,624,926) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 9 of 9
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,618,661 | Process for preparation of Rhus verniciflua extracts having excellent anti-cancer activity and anti-cancer pharmaceutical composition containing the same In force · From the USPTO record | In force | From the USPTO record | |
| US 8,771,976 | Method of Cancer Diagnosis Using the Analysis of Isotopes In force · High confidence | In force | High confidence | |
| US 8,551,537 | Rhus verniciflua stokes extract having increased content of active flavonoid compound and method for preparing same In force · From the USPTO record | In force | From the USPTO record | |
| US 8,859,014 | Method of converting fustin to fisetin In force · From the USPTO record | In force | From the USPTO record | |
| US 10,590,384 | Luterial and method for isolating and culturing the same In force · From the USPTO record | In force | From the USPTO record | |
| US 10,338,061 | Method for diagnosis of diseases using morphological characteristics of luterial In force · From the USPTO record | In force | From the USPTO record | |
| US 10,624,926 | Luterial and Method for Isolating and Culturing the Same In force · High confidence | In force | High confidence | |
| US 10,406,188 | Method for inhibiting telomerase in cancer cell using luterion In force · From the USPTO record | In force | From the USPTO record | |
| US 10,569,194 | Luterion and Separating and Culturing Methods for Same In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
Every application published under this name has become a patent.